Efficacy and safety of ustekinumab in Behçet disease: Results from the prospective phase 2 STELABEC trial.

Jonathan London Alexis Régent Jérémie Dion Léa Jilet Marie Jachiet Olivier Lidove Fleur Cohen-Aubart Selim Aractingi Sarah Guégan Jean-Loup Pennaforte Hendy Abdoul Xavier Puéchal Benjamin Terrier

J Am Acad Dermatol

Department of Internal Medicine, National Referral Center for Rare Systemic Autoimmune Diseases, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France; Université de Paris, France. Electronic address:

Published: September 2022

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.jaad.2021.11.045	DOI Listing

Publication Analysis

Top Keywords

efficacy safety

safety ustekinumab

ustekinumab behçet

behçet disease

disease prospective

prospective phase

phase stelabec

stelabec trial

efficacy

ustekinumab

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!